Your browser doesn't support javascript.
loading
Access to essential therapy for sickle cell disease in Africa: Experience from a national program in Ghana.
Nyonator, Christine; Amoah, Emefa; Addo, Etta Forson; Mukanga, Maureen; Asubonteng, Augustine Kwabena; Ohene-Frempong, Kwaku; Spector, Jonathan Michael; Ofori-Acquah, Solomon Fiifi.
Afiliação
  • Nyonator C; Novartis Global Health & Sustainability, East Hanover, New Jersey, United States.
  • Amoah E; Sickle Cell Foundation of Ghana, Accra, Ghana.
  • Addo EF; Sickle Cell Foundation of Ghana, Accra, Ghana.
  • Mukanga M; Novartis Global Health & Sustainability, Nairobi, Kenya.
  • Asubonteng AK; Sickle Cell Foundation of Ghana, Accra, Ghana.
  • Ohene-Frempong K; Sickle Cell Foundation of Ghana, Accra, Ghana.
  • Spector JM; Novartis Institutes for BioMedical Research, Cambridge, MassachuseUs, United States. Electronic address: jonathan.spector@novartis.com.
  • Ofori-Acquah SF; Sickle Cell Foundation of Ghana, Accra, Ghana.
Semin Hematol ; 60(4): 226-232, 2023 09.
Article em En | MEDLINE | ID: mdl-37481464

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme Tipo de estudo: Guideline Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme Tipo de estudo: Guideline Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article